• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROTYPING SYSTEMS BLOOD GROUPING REAGENT MTS A/B/D MONOCLONAL AND REVERSE GROUPING CARD; MTS GEL CARDS - BLOOD GROUPING REAGENTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROTYPING SYSTEMS BLOOD GROUPING REAGENT MTS A/B/D MONOCLONAL AND REVERSE GROUPING CARD; MTS GEL CARDS - BLOOD GROUPING REAGENTS Back to Search Results
Catalog Number MTS080515
Device Problem False Positive Result (1227)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 07/30/2019
Event Type  malfunction  
Manufacturer Narrative
Ortho performed retain testing, batch review, complaint review by lot and master lot.Based upon the results of this investigation, the reported customer issue was unable to be confirmed.All results were satisfactory.Sample was not returned to ortho for further investigation.(b)(4).
 
Event Description
Event 1 of 3.Account reporting possible false positive results with abd/reverse card lot 011019037-17 in the forward d(rh) typing with 3 patient samples.Customer last reported that 3 patients (1 in the last 2 weeks) and 2 earlier in the year, where forward d typing was originally 3+ but all patients later developed anti-d.Account also performed tube typing on the patients using ortho's anti-d bioclone (lot number not provided) and all three patients were is d negative, weak d positive.Issue started on: reported(b)(6) 2019.Microtubes/wells or cell (donor #) affected: forward d typing.Reaction grade obtained: 3+ customer was expecting: negative.Incubation time (for manual test only): unknown at this time.Test repeated: account only repeated vision results in manual gel.Method/result obtained by repeating: weak d positive.Daily qc performed and found to be acceptable.Product handling protocol: cassette/gel card storage temperature range: per ifu.Cassette/gel card orientation: upright.Rbc storage and handling: per ifu.Visual appearance before use: all reagents have a normal appearance prior to use.Opened vs unopened? unopened.Tsc explained to account that it is possible for a rh postive patient to form anti-d if they are missing part of the d antigen.Clones are different in gel vs tube reagents.31jul2019-followed up with customer: one patient was a (b)(6) female that was pregnant.Account typed her as b positive.She received rh positive units on (b)(6) 2019.On (b)(6) 2019 she displayed anti-d.Weak d reactivity with bioclone was 3+.Account denies that she received rhogam.Patient received transfusion as she has sickle cell anemia.02aug2019-followed up with account - second patient - female previously typed as a pos was sent to a reference lab due to the fact that they detected anti-d in the sample.Report came back as auto anti-d and anti-c.This was in (b)(6).Patient represented on (b)(6) 2019 with the auto anti-d still showing.Patient had received 6 rh positive units in (b)(6) 2018.A neighboring hospital called them for history.In their hands patient was rh negative with immucor echo.However, this account is still seeing 3+ positive on the vision with gel.Bioclone tube testing was weak d (b)(6) 2019- followed up with account.Third patient.(b)(6) pregnant female previously typed with tube as rh negative.Account received 3+ positive in gel on the vision.Sample was sent for molecular testing and came back as a partial d.Account is considering redoing their policy for how to handle rh positive women of child bearing age.Tss reviewed with account again that most likely cause of discrepancies noted are differences in clones used in commercial reagents.They all target a different portion of the d antigen.Account satisfied with explanation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BLOOD GROUPING REAGENT MTS A/B/D MONOCLONAL AND REVERSE GROUPING CARD
Type of Device
MTS GEL CARDS - BLOOD GROUPING REAGENTS
Manufacturer (Section D)
MICROTYPING SYSTEMS
1295 southwest 29th avenue
pompano beach FL 33069
Manufacturer (Section G)
MICROTYPING SYSTEMS
1295 southwest 29th avenue
pompano beach FL 33069
Manufacturer Contact
james a stevens
1001 route 202
raritan, NJ 08869
9082188223
MDR Report Key8903846
MDR Text Key218540575
Report Number1056600-2019-00030
Device Sequence Number1
Product Code KSZ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 08/16/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/16/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Expiration Date02/28/2020
Device Catalogue NumberMTS080515
Device Lot Number011019037-17
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/30/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/28/2019
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-